Cargando…

CD98hc as a marker of radiotherapy-resistant cancer stem cells in head and neck squamous cell carcinoma

INTRODUCTION: The prognosis of head and neck squamous cell carcinoma (HNSCC) is generally good in cases of high radiation sensitivity but poor in cases exhibiting radiation resistance; this resistance has been attributed to the presence of cancer stem cells. In recent years, CD98hc overexpression ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawasaki, Yohei, Omori, Yasufumi, Suzuki, Shinsuke, Yamada, Takechiyo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2020
Materias:	Basic Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696980/ http://dx.doi.org/10.5114/aoms.2020.92872

Ejemplares similares

LAT1 is associated with poor prognosis and radioresistance in head and neck squamous cell carcinoma
por: Kawasaki, Yohei, et al.
Publicado: (2023)

GPNMB-Positive Cells in Head and Neck Squamous Cell Carcinoma—Their Roles in Cancer Stemness, Therapy Resistance, and Metastasis
por: Kawasaki, Yohei, et al.
Publicado: (2022)

Intrinsic Oncogenic Function of Intracellular Connexin26 Protein in Head and Neck Squamous Cell Carcinoma Cells
por: Iikawa, Nobuko, et al.
Publicado: (2018)

Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma
por: Suzuki, Hitomi, et al.
Publicado: (2022)

Irradiated fibroblasts increase interleukin-6 expression and induce migration of head and neck squamous cell carcinoma
por: Suzuki, Shinsuke, et al.
Publicado: (2022)

SDF-1/CXCR4 induces cell invasion through CD147 in squamous cell carcinoma of the hypopharynx
por: Toyoma, Satoshi, et al.
Publicado: (2020)

Prognostic role of regenerating gene-I in patients with stage-IV head and neck squamous cell carcinoma
por: Aboshanif, Mohamed, et al.
Publicado: (2016)

Association of Pretreatment Neutrophil-to-Eosinophil Ratio with Clinical Outcomes in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Treated with Nivolumab
por: Suzuki, Shinsuke, et al.
Publicado: (2022)

The investigation of salvage endoscopic laryngopharyngeal surgery after chemoradiotherapy
por: Kawasaki, Yohei, et al.
Publicado: (2020)

Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
por: Köseer, Ayşe Sedef, et al.
Publicado: (2022)

An investigation on endoscopic laryngopharyngeal surgery and related outcomes
por: Kawasaki, Yohei, et al.
Publicado: (2018)

Clinical Outcomes of Cetuximab and Paclitaxel after Progression on Immune Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Suzuki, Shinsuke, et al.
Publicado: (2021)

CD98hc facilitates B cell proliferation and adaptive humoral immunity
por: Cantor, Joseph, et al.
Publicado: (2009)

Conditional deletion of CD98hc inhibits osteoclast development
por: Tsumura, Hideki, et al.
Publicado: (2015)

CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023)

Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior
por: Bianconi, Daniela, et al.
Publicado: (2022)

Extracellular domain of CD98hc is required for early murine development
por: Sato, Yukiyasu, et al.
Publicado: (2011)

Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2)
por: Fogelstrand, Per, et al.
Publicado: (2009)

CD244 represents a new therapeutic target in head and neck squamous cell carcinoma
por: Agresta, Laura, et al.
Publicado: (2020)

Author Correction: CD98hc is a target for brain delivery of biotherapeutics
por: Chew, Kylie S., et al.
Publicado: (2023)

18F-FDG-PET/CT can be used to predict distant metastasis in hypopharyngeal squamous cell carcinoma
por: Suzuki, Shinsuke, et al.
Publicado: (2022)

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior
por: Poettler, Marina, et al.
Publicado: (2013)

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells
por: D’Agostino, Sabrina, et al.
Publicado: (2018)

CD98hc (SLC3A2) regulation of skin homeostasis wanes with age
por: Boulter, Etienne, et al.
Publicado: (2013)

CD98hc (SLC3A2) sustains amino acid and nucleotide availability for cell cycle progression
por: Cano-Crespo, Sara, et al.
Publicado: (2019)

Fadu head and neck squamous cell carcinoma induces hyperexcitability of primary sensory neurons in an in vitro coculture model
por: Uhelski, Megan L., et al.
Publicado: (2022)

Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice
por: Deuschle, Friedrich‐Christian, et al.
Publicado: (2020)

Development of a high affinity Anticalin(®) directed against human CD98hc for theranostic applications
por: Deuschle, Friedrich-Christian, et al.
Publicado: (2020)

Radiotherapy Quality Assurance for Head and Neck Squamous Cell Carcinoma
por: Van Gestel, Dirk, et al.
Publicado: (2020)

CD98hc has a pivotal role in maintaining the immuno-barrier integrity of basal layer cells in esophageal epithelium
por: Ye, Hao, et al.
Publicado: (2022)

CD98hc (SLC3A2) participates in fibronectin matrix assembly by mediating integrin signaling
por: Féral, Chloé C., et al.
Publicado: (2007)

Loss of the branched-chain amino acid transporter CD98hc alters the development of colonic macrophages in mice
por: Wuggenig, Philipp, et al.
Publicado: (2020)

Prognostic values of L-type amino acid transporter 1 and CD98hc expression in breast cancer
por: Ichinoe, Masaaki, et al.
Publicado: (2021)

Surfaceome analyses uncover CD98hc as an antibody drug-conjugate target in triple negative breast cancer
por: Montero, Juan Carlos, et al.
Publicado: (2022)

4373 Defining the role of non-canonical PIK3CA mutations in head and neck squamous cell carcinoma
por: Lee, Michelle Ji-Eun, et al.
Publicado: (2020)

High mobility group A2 is a target for miRNA-98 in head and neck squamous cell carcinoma
por: Hebert, Carla, et al.
Publicado: (2007)

Efficacy of Arytenoidectomy after Suture Lateralisation Failure in Patients with Bilateral Vocal Cord Paralysis
por: Suzuki, Shinsuke, et al.
Publicado: (2020)

Concurrent radiotherapy and chemotherapy for locally advanced squamous cell carcinoma of the head and neck
por: Ali, Elsayed M, et al.
Publicado: (2011)

Reprogramming of Energy Metabolism in Response to Radiotherapy in Head and Neck Squamous Cell Carcinoma
por: Cruz-Gregorio, Alfredo, et al.
Publicado: (2019)

Head and Neck Squamous Cell Carcinoma in Elderly Patients: Role of Radiotherapy and Chemotherapy
por: Fasano, Morena, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o8c8f0gret79gnmgojlpuvcufk